ArticleMedical oncology (Northwood, London, England)2025
Association of thymoquinone-induced changes in PINK1, DRP1, TFEB, and cytochrome c expression with mitochondrial dynamics and apoptosis in HepG2 and HDF cells.
Article in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Healthy mitochondria and mitochondrial quality control are essential for vital cell activities. Cell health is fundamentally maintained by the coordinated regulation of processes such as mitochondrial fusion, fission, and mitophagy. Their disruption plays a role in cancer pathogenesis, as well as in many diseases. This study investigated the effects of thymoquinone (TQ), a bioactive compound from Nigella sativa, on mitochondrial dynamics and quality control in Hepatocellular Carcinoma Cells (HepG2) and Human Dermal Fibroblasts (HDF). Results from molecular techniques such as the MTT assay, colony formation assay, wound healing assay, DAPI staining, and JC-1 staining, as well as Real-Time Polymerase Chain Reaction (RT-PCR) and Western blot analysis, were evaluated. TQ treatment caused dose-dependent decreases in cell viability and migration in both cell types, according to the MTT and wound healing assay results. While nuclear morphology assessments with DAPI staining served as a parameter for apoptotic changes, JC-1 analysis revealed a significant loss of mitochondrial membrane potential (ΔΨm) in HepG2 cells, while a relatively milder decrease was observed in HDF cells. At the molecular level, TQ exposure increased Cytochrome c (Cyt c) and Transcription Factor EB (TFEB) levels in both cell lines, but Dynamin-Related Protein 1 (DRP1) upregulation was more pronounced in HDF cells. Specifically, Western blot results showed an increase in PTEN-Induced Kinase 1 (PINK1) protein in HepG2 cells, but not in HDF cells. These findings suggest that TQ can trigger the mitochondrial stress response in HepG2 cells through DRP1-dependent fission, TFEB-associated lysosomal activation, and PINK1-associated mitophagy signaling. The stronger suppression of ΔΨm and PINK1 induction in HepG2 suggests an increased likelihood of activation of the intrinsic apoptotic pathway, while the partial preservation of mitochondrial integrity in HDF cells suggests a mild adaptation to stress. Further studies on mitophagy flux, Cyt c intracellular distribution, and TFEB nuclear translocation will be needed to define the mechanisms underlying these cell-type-specific responses.
Indexed as
Identifiers
41379258What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.